AHCO

AdaptHealth Corp. Common Stock (AHCO)

Stock · NASDAQ · Health Care

$6.03as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

AdaptHealth (AHCO) flagged in Yahoo's cautionary stock list. A recent Yahoo article placed AHCO among three stocks that Wall Street should think twice about. The piece suggests investors may need to re‑evaluate expectations for the company. The stock is currently near its long‑term support level of $5.70 and shows a moderate RSI, which aligns with the cautious tone of the article.

Active signals

Support level
$5.7
Industry
Medical/Nursing Services

What AHCO's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike39+0.4%51%
Bollinger Band Breakout23-3.5%39%
200-Day Moving Average TouchActive now23+1.0%61%
Bollinger Band Breakdown21+3.3%57%
Any 20-session window (baseline)-0.4%48%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About AHCO

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals…

Sector
Health Care
Industry
Medical/Nursing Services
Employees
10,900

Fundamentals

1-day range
$6$6.44
Market cap
$824.20M
P/E (trailing)
—
P/E (forward)
-47.78
EPS (trailing)
$-1.68
Dividend yield
—
Beta
1.34
Avg. volume
3.00M
52-week range
$5.21$13.43
Next earnings: November 3, 2026 · EPS estimate $-0.06Before Openconfirmed

How AdaptHealth Corp. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$3.24BCost of Revenue$2.64B (81%)SG&A$382.29M (12%)Other$176.02M (5%)Tax$50.88M (2%)AHCO

Source: 10-K filed Feb 24, 2026 · via SEC EDGAR / Finnhub

Gross Profit$609.20M(19%)
Operating Income$90.87M(3%)

Forecasts

7 analyst ratings

Buy 92%
Hold 8%
Sell 0%
1-year price forecast
High
$10
+65.8%
Median
$9
+49.3%
Low
$7
+16.1%

AdaptHealth Corp. Common Stock Competitors

Chosen by industry and closest market cap.

  • AHCO
    AdaptHealth Corp. Common Stock
    $6.02
    ▼ 5.79%
    Market cap $824.20MP/E —
    $5.21$13.43
  • LFMDP
    LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock
    $22.18
    ▲ 0.81%
    Market cap $1.12BP/E 589.89
    $2.36$6.53
  • STLN
    Starling Oncology Inc. Common Stock
    $6.43
    ▼ 7.02%
    Market cap $498.91MP/E —
    $4.85$7.13
  • SRTA
    Strata Critical Medical Inc. Class A Common Stock
    $4.54
    ▲ 4.61%
    Market cap $494.53MP/E 9.58
    $3.95$6.5
  • OMDA
    Omada Health Inc. Common Stock
    $17.63
    ▼ 5.57%
    Market cap $1.16BP/E 265.49
    $10.28$26.92
  • USPH
    U.S. Physical Therapy Inc. Common Stock
    $85.71
    ▼ 0.31%
    Market cap $1.16BP/E 39.50
    $58.19$93.5
  • TDOC
    Teladoc Health Inc. Common Stock
    $5.67
    ▼ 5.03%
    Market cap $1.21BP/E —
    $4.4$9.89

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
362.9K
Disposed
22.6K

Institutional Ownership

March 31, 2026

Total shares held
136.26M
Total value held
$1.59B
Institutional holders
232
Top holders this quarter
  • Unknown16.31M
  • Unknown15.94M
  • Unknown11.48M
  • Unknown10.08M
  • Unknown8.58M
  • Unknown8.05M
  • Unknown6.92M
  • Unknown4.50M
  • Unknown4.30M
  • Unknown3.48M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.